RAD51C and ovarian cancer: One of 3 mutations in RAD51C was seen in 15 out of 2095 (0.72%) ovarian cancer cases and in 2 out of 1743 controls (0.11%) (OR = 6.28; 95% CI 1.77–39.9; p = 0.02).